Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
Cholera01:25

Cholera

Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of the genetic and phylogenetic context of <i>Escherichia coli</i> O77g:H18 associated with clustered cases of HUS in France in 2025.

Applied and environmental microbiology·2026
Same author

Impact of non-pharmaceutical interventions during the early phase of COVID-19 pandemic on paediatric ICU admissions in Canada and France: a multicentre descriptive cohort and interrupted time-series analysis of non-SARS-CoV-2 viral admissions.

BMJ public health·2026
Same author

Nationwide outbreak of Shiga toxin-producing <i>Escherichia coli</i> infections associated with frozen pizzas, France, 2022.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

A public resource of 15 genomically characterized representative strains of <i>Shigella sonnei</i>.

Microbial genomics·2026
Same author

Modeling the spatio-temporal spread of cholera in France in 1892.

Epidemics·2025
Same author

Genomic characterisation of multidrug-resistant <i>Salmonella enterica</i> serovar Kentucky ST198 isolates from various sources in Algeria, North Africa.

Microbial genomics·2025
Same journal

Detection of and Early Genomic Insights into Chikungunya Virus, Bolivia, 2025.

Emerging infectious diseases·2026
Same journal

Household Transmission of Enterovirus D68, Washington and Oregon, United States, 2022-2024.

Emerging infectious diseases·2026
Same journal

New World Ocular Dirofilariasis Caused by Dirofilaria repens Infection, United States.

Emerging infectious diseases·2026
Same journal

Angiostrongylus cantonensis Rat Lungworm Detected in Rats, Madagascar, 2022-2023.

Emerging infectious diseases·2026
Same journal

Human Pulmonary Dirofilariasis,
North Queensland, Australia, 2023<sup>1</sup>.

Emerging infectious diseases·2026
Same journal

Trends in Congenital Syphilis Cases by Maternal Country of Birth, Spain, 2016-2024.

Emerging infectious diseases·2026
See all related articles

Related Experiment Video

Updated: Jul 3, 2026

Epithelial Cell Infection Analyses with Shigella
04:56

Epithelial Cell Infection Analyses with Shigella

Published on: February 9, 2024

Macrolide-resistant Shigella sonnei.

Leyla Boumghar-Bourtchai1, Patricia Mariani-Kurkdjian, Edouard Bingen

  • 1Centre Hospitalier Universitaire Côte de Nacre, Caen, France.

Emerging Infectious Diseases
|August 6, 2008
PubMed
Summary
This summary is machine-generated.

Shigella sonnei UCN59 exhibited resistance to azithromycin due to the mph(A) gene. This macrolide resistance mechanism may reduce azithromycin

More Related Videos

Imaging Ca2+ Responses During Shigella Infection of Epithelial Cells
08:56

Imaging Ca2+ Responses During Shigella Infection of Epithelial Cells

Published on: May 24, 2018

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

Related Experiment Videos

Last Updated: Jul 3, 2026

Epithelial Cell Infection Analyses with Shigella
04:56

Epithelial Cell Infection Analyses with Shigella

Published on: February 9, 2024

Imaging Ca2+ Responses During Shigella Infection of Epithelial Cells
08:56

Imaging Ca2+ Responses During Shigella Infection of Epithelial Cells

Published on: May 24, 2018

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Shigellosis is a bacterial infection that can be treated with azithromycin.
  • Antibiotic resistance is a growing concern in treating bacterial infections.

Observation:

  • A Shigella sonnei isolate, UCN59, was identified during a 2007 outbreak.
  • This isolate showed significant resistance to azithromycin, with a minimum inhibitory concentration (MIC) of 64 mg/L.

Findings:

  • The UCN59 isolate harbored a plasmid carrying the mph(A) gene.
  • The mph(A) gene encodes a macrolide 2'-phosphotransferase, an enzyme that inactivates macrolide antibiotics.
  • This genetic mechanism confers azithromycin resistance in Shigella sonnei.

Implications:

  • The emergence and spread of the mph(A) gene in Shigella sonnei could compromise the efficacy of azithromycin for treating shigellosis.
  • This finding highlights the need for ongoing surveillance of antimicrobial resistance in bacterial pathogens.
  • Alternative treatment strategies may be required for shigellosis cases infected with resistant strains.